Literature DB >> 2679851

Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells.

M Bontenbal1, A M Sieuwerts, J G Klijn, H A Peters, H L Krijnen, P Sonneveld, J A Foekens.   

Abstract

Dual-parameter flow cytometry, following bromodeoxyuridine (BrdUrd) incorporation and propidium iodide (PI) uptake into DNA, was used to study the effects of oestradiol and/or insulin on cell cycle kinetics of human breast cancer cells in vitro. After a lag-period of 6-12 h, an optimum in the percentage of S-phase cells was reached between 18 and 24 h after hormone administration. A 1 h pulse of oestradiol was as effective as the continuous presence of oestradiol in pushing the cells from quiescent growing cultures into the cell cycle. A 1 h pulse of insulin was less effective than continuous administration. The addition of doxorubicin resulted in an accumulation of the cells in the late S/G2M-phases. It is concluded that dual-parameter flow cytometry allows accurate assessment of the effects of hormones and chemotherapy on the cell cycle. Therefore this method is very suitable for studying the interaction of hormones and chemotherapy on cell growth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679851      PMCID: PMC2247289          DOI: 10.1038/bjc.1989.341

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

Review 1.  Cell cycle analysis using flow cytometry.

Authors:  J W Gray; F Dolbeare; M G Pallavicini; W Beisker; F Waldman
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1986-02

2.  Combined chemo-hormonal therapy in breast cancer: a hypothesis.

Authors:  C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

3.  Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.

Authors:  R R Weichselbaum; S Hellman; A J Piro; J J Nove; J B Little
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

4.  Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.

Authors:  A Krishan; E Frei
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

5.  Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7).

Authors:  M Bontenbal; P Sonneveld; J A Foekens; J G Klijn
Journal:  Eur J Cancer Clin Oncol       Date:  1988-09

6.  Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.

Authors:  P F Conte; P Pronzato; A Rubagotti; A Alama; D Amadori; R Demicheli; G Gardin; P Gentilini; A Jacomuzzi; R Lionetto
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

7.  Use of growth-stimulatory hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors.

Authors:  V Hug; D Johnston; M Finders; G Hortobagyi
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

8.  Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.

Authors:  R Clarke; H W Van den Berg; D G Kennedy; R F Murphy
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

  8 in total
  3 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

2.  Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.

Authors:  J A Foekens; A M Sieuwerts; E M Stuurman-Smeets; H A Peters; J G Klijn
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

Review 3.  Risk of cancer in diabetes: the effect of metformin.

Authors:  Mojtaba Malek; Rokhsareh Aghili; Zahra Emami; Mohammad E Khamseh
Journal:  ISRN Endocrinol       Date:  2013-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.